Pharma Summit 2007

2006 Highlights | 2005 Highlights

Pharma Summit 2007: “India Pharma Inc. – A Continuing Success Story ”

Thursday, 1 November 2007: MMRDA Grounds, Bandra Kurla Complex, Bandra (East) Mumbai

Programme

0945 – 1130 hrs Inaugural Plenary
Over the last few years, the global competitive landscape has seen the emergence of competitors from emerging or rapidly developing economies. Indian companies have also played their part in this new phenomenon. The inaugural plenary attempts to look back at the path traversed and the path yet to be undertaken. The plenary aims at not only contributing new inputs but also draw parallels from noteworthy lessons towards making India 's pharma story, consistent and successful. This plenary also aims at giving an overview of the essence of the Summit apart from providing effective insights about the performance and prospects, of the Indian Pharma Industry.

Inaugural Plenary
0945 – 1000 hrs	Inauguration and Visit to Chem Expo 2007 / Pharma Expo 2007

1000 – 1010 hrs	Welcome and Introductory Remarks	Shrinivas V Dempo Chairman – CII Western Region and Chairman & Managing Director V S Dempo & Co. Pvt. Ltd.

1010 – 1030 hrs	Keynote Address by Chief Guest India Pharma Inc.: A Continuing Growing Success Story	Renuka Ramnath Managing Director & Chief Executive Officer ICICI Venture Funds Management Co.Ltd.

1030 – 1035 hrs	Release of CII-KPMG Report on “India Pharma Inc. – A Continuing Success Story”

1035 – 1100 hrs	The Summit & its Objectives	Dr Swati Piramal Director – Strategic Alliances & Communications Nicholas Piramal India Ltd.

1100 – 1120 hrs	Overview on the Report	John Morris Global Chair – Chemicals & Pharmaceuticals KPMG, United Kingdom

1120 – 1130 hrs	Vote of Thanks	Shrinivas V Dempo

1130 – 1200 hrs	Tea / Coffee Break

Plenary I : 1200 – 1315 hrs: “India Pharma Inc. – The Year That Was - Analysis & Prognosis ”: This session will emphasise upon the key drivers and growth enablers of the Indian Pharma Industry in the world's largest markets largely supported by facts and figures. Besides discussing the challenges and measures which make the business models deliver, the success stories of Joint Venture and collaborations will also be discussed. The session would also encompass a broader global vision of growth, expansion, new markets and mergers and acquisitions in the Indian Pharma Industry. It is also attempted to shed some light on the performance of the mergers and acquisitions in terms of their management and the return on Investment.

1200 – 1210 hrs

Introduction by Session Chairperson

Dr Swati Piramal

1210 – 1230 hrs

India Pharma Inc. The Year That Was – Industry Statistics, Trends, Challenges – Future Potential

Hitesh Gajaria
Executive Director
KPMG India Pvt. Ltd.

1230 – 1250 hrs

India Pharma Inc. – The success of Joint Ventures, Collaborations - What makes these models work, the challenges and measures to make such models deliver results, consistently

Pankaj R Patel
Chairman & Managing Director
Cadila Healthcare Ltd.

1250 – 1310 hrs

India Pharma Inc. – Global Focus - Growth, Expansion, New Markets and M & A's

John Morris

1310 – 1315 hrs

Question & Answer followed by Concluding Remarks

Dr Swati Piramal

1315 – 1400 hrs

Lunch

Plenary II: 1400 – 1600 hrs: “India Pharma Inc. – Business Landscape, Emerging Opportunities & Challenges”: India Inc. has been growing at an explosive pace, over the last decade. Indian corporates have reached milestone after milestone in many sectors today. This session would discuss the current industry environment, business fundamentals and the global opportunities thereby, also presenting an analyst's perspective of the drivers of valuation, in each of the sub sectors. Further, the session aims at showcasing the technology challenges as faced by various facets of the industry be it the production, distribution or product development. Given the fact that the world is shrinking to a global village with things moving into easy reach, this session would also focus on the impact of improved connectivity for the Indian Pharma Inc, in future.

1400 – 1410 hrs	Introduction by Session Chairman	Pankaj R Patel

1410 – 1430 hrs	Global Opportunities for Indian Pharma Players	G V Prasad Vice Chairman & Chief Executive Officer Dr Reddy's Laboratories Ltd.

1430 – 1450 hrs	India Pharma Inc. – Reflections on the Global Marketplace	Dr Brian Tempest Chief Mentor & Executive Vice – Chairman of the Board Ranbaxy Laboratories Ltd.

1450 – 1510 hrs	India Pharma Inc. – Current Industry Business Fundamentals and Valuation Drivers for each of the Sub Sectors	Probir Rao Managing Director Investment Banking UBS Securities India Pvt. Ltd.

1510 – 1530 hrs	India Pharma Inc. – Strategic Technology Challenges in Pharma R&D, Manufacturing and Sales & Distribution	N C Raghu Ram Director & Chief Executive Officer Spectrasoft Technologies Ltd.

1530 – 1550 hrs	India Pharma Inc. – Improve Cost Efficiency and Profitability Through Effective Connectivity – User Perspective and Experiences	Darayus Mehta Head - Broadband Applications Reliance WebStores Ltd. Satish Mansukhani Deputy General Manager - Marketing Unichem Laboratories Ltd.

1550 – 1600 hrs	Question & Answer followed by Concluding Remarks	Pankaj R Patel

1600 – 1620 hrs	Tea / Coffee Break

Plenary III : 1620 – 1805 hrs “India Pharma Inc. – The Road Ahead”: This session deals with the future course of action and the game plan to be adopted by the MNCs in order to derive better benefits especially in the light of intense competition form the domestic Pharma majors. The Generic Business models, which will aid in adapting in a seemingly adverse environment, would also be highlighted upon along with the innovative funding and success models in the face of enhanced R & D expenditures and the idea of partnering opportunities under CRAMS. It will also focus and highlight the role played by the IT and the Logistics as facilitators for the industry in adopting the most optimal way of production and distribution, thereby, gaining economies on the costs involved.

1620 – 1625 hrs	Introduction by Session Chairman	Dr Brian Tempest

1625 – 1645 hrs	MNC Pharma Companies in India – The Road Ahead and the Game Plan	Ranga Iyer President - Organisation of Pharmaceutical Producers of India and Managing Director Wyeth Ltd.

1645 – 1705 hrs	India Pharma Inc. – Research and Development and New Chemical Entities – Innovative Funding and Success Models in the face of increasing R & D spend	Glenn Saldanha Managing Director & Chief Executive Officer Glenmark Pharmaceuticals Ltd.

1705 – 1725 hrs	CRAMS: Successful Partnering Strategies and Scalable Opportunities – Key Learning's	Jatin Lal General Manager - Strategic Planning Nicholas Piramal India Ltd.

1725 – 1745 hrs	India Pharma Inc.- Improve Cost Efficiency and Profitability Through Effective Logistics"	Lemaire Stephane Director – Pharma Industry Air France KLM Cargo - Netherlands

1745 – 1800 hrs	India Pharma Inc.- IT– Enabler for the Pharma Industry	Vikas Bajaj Regional Manager - Mid Market, West IBM India Pvt Ltd.

1800 – 1805 hrs	Question & Answer followed by Concluding Remarks	Dr Brian Tempest

1810 – 1915 hrs: CEO's Interactive Roundtable: “India Pharma Inc. – A Continuing Success Story”

Vikas Dandekar
Bureau Chief,Mumbai
CNBC TV18
Television Eighteen India Limited

This thought provoking interactive roundtable session aims at bringing together the eminent thought leaders who are leading players in the Indian Pharmaceutical Industry on a common platform. Each of the panelists would share their views on critical areas of concern impacting upon the Indian Pharma Industry ie. Growth, Globalization, Compliance and Vision. This interactive round table will also attempt to enable the Pharma Industry to crystallize the path ahead for its players in the domestic and global arena and ensure best practice, which would endorse safe and profitable for the Pharma industry.
This session will endeavour to live up to its theme of “India Pharma Inc – A Continuing Success Story”

	Dr Swati Piramal Director – Strategic Alliances & Communications Nicholas Piramal India Ltd.	Kewal Handa Managing Director Pfizer Ltd.

	Dr Brian Tempest Chief Mentor & Executive Vice – Chairman of the Board Ranbaxy Laboratories Ltd.	Pankaj R Patel Chairman & Managing Director Cadila Healthcare Ltd.

	G V Prasad Vice Chairman & Chief Executive Officer Dr Reddy's Laboratories Ltd.	Dr Kiran Mazumdar Shaw Chairman & Managing Director Biocon Ltd.

	Ranga Iyer President Organisation of Pharmaceutical Producers of India and Managing Director Wyeth Ltd.	Dr Ferzaan Engineer Chief Executive Officer Quintiles Research ( India ) Pvt. Ltd.

	John Morris Global Chair – Chemicals & Pharmaceuticals KPMG, United Kingdom	Glenn Saldanha Managing Director & Chief Executive Officer Glenmark Pharmaceuticals Ltd.

1915 – 1930 hrs	Q & A Session followed by Concluding Remarks


Download Invitation for Knowledge Workshop
Download Delegate Registration form

Back			Next

Website design by Nucent Technologies